JOSEPH C KENNEDY
Broker in Boston, MA
License number
Massachusetts 9041764
Issued Date
Nov 7, 2001
Expiration Date
May 4, 2005
Type
Salesperson
Address
Address
Boston, MA 02135
Organization information
See more information about JOSEPH C KENNEDY at bizstanding.comJOSEPH C. KENNEDY, JR., PC
54 Canal St, Boston, MA 02114
Status:
Inactive
Registration:
Jan 30, 1992
Inactive since:
Jun 18, 2012
State ID:
043143012
Business type:
Professional Corporation
President:
Joseph C. Kennedy Jr (President), 27 High St, Charlestown, MA (Physical)
Professional information
Joseph Patrick Kennedy, Boston MA - Lawyer
Address:
125 Fl Oliver St #Tower, Boston 02110
(617) 368-2510, (617) 368-2525
(617) 368-2510, (617) 368-2525
Licenses:
Massachusetts - Active 1994
Education:
Vermont Law SchoolDegree JD - Juris Doctor
Specialties:
Patent Infringement - 34%
Lawsuits / Disputes - 33%
Commercial - 33%
Lawsuits / Disputes - 33%
Commercial - 33%
Scientific Software Analyst At Vertex Pharmaceuticals
Position:
Scientific Software Analyst at Vertex Pharmaceuticals
Location:
Greater Boston Area
Industry:
Research
Work:
Vertex Pharmaceuticals
since Apr 2012
-
Scientific Software Analyst
Vertex Pharmaceuticals
Jun 2008 - Apr 2012
-
Senior Research Associate
Yale University
Jul 2007 - Jun 2008
-
Graduate Student
Education:
Yale University 2007 - 2008
Master of Science (MS), Organic Chemistry Boston College 2003 - 2007
BS, Chemistry
Master of Science (MS), Organic Chemistry Boston College 2003 - 2007
BS, Chemistry
Dr. Joseph L Kennedy, Boston MA - MD (Doctor of Medicine)
Specialties:
Neonatal Medicine
Address:
103 Warren Ave, Boston 02116
(617) 262-8280 (Phone), (617) 266-2346 (Fax)
(617) 262-8280 (Phone), (617) 266-2346 (Fax)
Certifications:
Pediatrics, 1964, Perinatal Medicine & Neonatal Medicine, 1975
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Tufts University
Boston Fltg Hosp
Childrens Hospital
Tufts University
Boston Fltg Hosp
Childrens Hospital
Owner, Blaisdell Rd Llc
Position:
Owner at BLAISDELL RD LLC
Location:
Greater Boston Area
Industry:
Building Materials
Work:
BLAISDELL RD LLC
-
Owner
Inhibitors Of Influenza Viruses Replication
US Patent:
2014000, Jan 2, 2014
Filed:
Jun 14, 2013
Appl. No.:
13/918110
Inventors:
Michael P. Clark - Concord MA, US
Ioana Davies - Watertown MA, US
Huai Gao - Arlington MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Ioana Davies - Watertown MA, US
Huai Gao - Arlington MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D 471/04
US Classification:
514242, 546119, 435238, 514303, 544405, 51425505, 544182
Abstract:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Inhibitors Of Influenza Viruses Replication
US Patent:
2012017, Jul 5, 2012
Filed:
Dec 15, 2011
Appl. No.:
13/327206
Inventors:
Paul S. Charifson - Framingham MA, US
Michael P. Clark - Concord MA, US
Upul K. Bandarage - Lexington MA, US
Randy S. Bethiel - Lexington MA, US
John J. Court - Littleton MA, US
Hongbo Deng - Southborough MA, US
Ioana Davies - Watertown MA, US
John P. Duffy - Northborough MA, US
Luc J. Farmer - Montreal, CA
Huai Gao - Arlington MA, US
Wenxin Gu - Concord MA, US
Dylan H. Jacobs - Everett MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Brian Ledford - Norton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Tiansheng Wang - Concord MA, US
M. Woods Wannamaker - Bolton MA, US
Randal Byrn - Wayland MA, US
Yi Zhou - Lexington MA, US
Chao Lin - Winchester MA, US
Min Jiang - Lexington MA, US
Steven Jones - Hyde Park MA, US
Ursula A. Germann - Newton MA, US
Michael P. Clark - Concord MA, US
Upul K. Bandarage - Lexington MA, US
Randy S. Bethiel - Lexington MA, US
John J. Court - Littleton MA, US
Hongbo Deng - Southborough MA, US
Ioana Davies - Watertown MA, US
John P. Duffy - Northborough MA, US
Luc J. Farmer - Montreal, CA
Huai Gao - Arlington MA, US
Wenxin Gu - Concord MA, US
Dylan H. Jacobs - Everett MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Brian Ledford - Norton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Tiansheng Wang - Concord MA, US
M. Woods Wannamaker - Bolton MA, US
Randal Byrn - Wayland MA, US
Yi Zhou - Lexington MA, US
Chao Lin - Winchester MA, US
Min Jiang - Lexington MA, US
Steven Jones - Hyde Park MA, US
Ursula A. Germann - Newton MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
International Classification:
A61K 39/145, A61K 31/506, A61K 31/5377, A61K 31/551, A61K 31/553, A01P 1/00, A01N 43/90, C07D 491/08, C07D 491/107, A61P 31/16, A61P 37/04, C07D 471/04, A61K 31/55
US Classification:
4242091, 544328, 514256, 544122, 5142345, 51421018, 544327, 544295, 51425218, 540575, 514218, 540544, 51421115, 540524, 51421208, 51421021, 540599, 540488, 51421103, 544230, 51425505, 51421016, 51421706
Abstract:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Inhibitors Of Influenza Viruses Replication
US Patent:
2014000, Jan 2, 2014
Filed:
Jun 14, 2013
Appl. No.:
13/918048
Inventors:
Michael P. Clark - Concord MA, US
Upul K. Bandarage - Lexington MA, US
Ioana Davies - Watertown MA, US
John P. Duffy - Northborough MA, US
Huai Gao - Arlington MA, US
Jun Feng - Acton MA, US
Jianglin Liang - Needham MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Brian Ledford - Norton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Upul K. Bandarage - Lexington MA, US
Ioana Davies - Watertown MA, US
John P. Duffy - Northborough MA, US
Huai Gao - Arlington MA, US
Jun Feng - Acton MA, US
Jianglin Liang - Needham MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Brian Ledford - Norton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D 471/04, A61K 31/506, A61K 45/06, A61K 31/5377
US Classification:
5142342, 544122, 544328, 514275, 544230, 435238
Abstract:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Inhibitors Of Influenza Viruses Replication
US Patent:
2013034, Dec 26, 2013
Filed:
Jun 14, 2013
Appl. No.:
13/918115
Inventors:
Michael P. Clark - Concord MA, US
Upul K. Bandarage - Lexington MA, US
Hongbo Deng - Southborough MA, US
Ioana Davies - Watertown MA, US
John P. Duffy - Northborough MA, US
Luc J. Farmer - Montreal, CA
Huai Gao - Arlington MA, US
Wenxin Gu - Concord MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Brian Ledford - Norton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Marion W. Wannamaker - Bolton MA, US
Tiansheng Wang - Concord MA, US
Francesco G. Salituro - Marlborough MA, US
Upul K. Bandarage - Lexington MA, US
Hongbo Deng - Southborough MA, US
Ioana Davies - Watertown MA, US
John P. Duffy - Northborough MA, US
Luc J. Farmer - Montreal, CA
Huai Gao - Arlington MA, US
Wenxin Gu - Concord MA, US
Joseph M. Kennedy - Charlestown MA, US
Mark W. Ledeboer - Acton MA, US
Brian Ledford - Norton MA, US
Francois Maltais - Tewksbury MA, US
Emanuele Perola - Brookline MA, US
Marion W. Wannamaker - Bolton MA, US
Tiansheng Wang - Concord MA, US
Francesco G. Salituro - Marlborough MA, US
International Classification:
C07D 471/04
US Classification:
5142345, 544331, 514275, 544127, 546113, 514300, 544182, 514242, 544212, 514245
Abstract:
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I):or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Dna-Pk Inhibitors
US Patent:
2014004, Feb 13, 2014
Filed:
Oct 17, 2013
Appl. No.:
14/056560
Inventors:
Kevin Michael Cottrell - Cambridge MA, US
Hongbo Deng - Southborough MA, US
John P. Duffy - Northborough MA, US
Huai Gao - Arlington MA, US
Simon Giroux - Cambridge MA, US
Jeremy Green - Waltham MA, US
Katrina Lee Jackson - Cambridge MA, US
Joseph M. Kennedy - Charlestown MA, US
David J. Lauffer - Stow MA, US
Mark Willem Ledeboer - Acton MA, US
Pan Li - Lexington MA, US
John Patrick Maxwell - Hingham MA, US
Mark A. Morris - Somerville MA, US
Albert Charles Pierce - Cambridge MA, US
Nathan D. Waal - Cambridge MA, US
Jinwang Xu - Framingham MA, US
Hongbo Deng - Southborough MA, US
John P. Duffy - Northborough MA, US
Huai Gao - Arlington MA, US
Simon Giroux - Cambridge MA, US
Jeremy Green - Waltham MA, US
Katrina Lee Jackson - Cambridge MA, US
Joseph M. Kennedy - Charlestown MA, US
David J. Lauffer - Stow MA, US
Mark Willem Ledeboer - Acton MA, US
Pan Li - Lexington MA, US
John Patrick Maxwell - Hingham MA, US
Mark A. Morris - Somerville MA, US
Albert Charles Pierce - Cambridge MA, US
Nathan D. Waal - Cambridge MA, US
Jinwang Xu - Framingham MA, US
International Classification:
C07D 491/048, C07D 471/04, C07D 401/12, C07D 401/14
US Classification:
51426621, 544328, 514256, 544296, 514274, 544284, 435375
Abstract:
The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Joseph Kennedy, Boston MA - Lawyer
Address:
1 Post Office Sq, Boston, MA 02109
Experience:
31 years
Specialties:
Business Law
Jurisdiction:
DC (1995)
Memberships:
District of Columbia Bar (1995)